It’s time for a different solution in diuresis.
As soon as signs and symptoms of fluid overload present in your heart failure, chronic kidney disease, and cardiorenal patients, it’s time for 99.6% absolute bioavailability with FUROSCIX.1
furoscix, a subcutaneous formulation of furosemide delivered as 80 mg over 5 hours,* provides early and effective treatment of fluid overload by:
bypassing the GI tract to provide 99.6% bioavailability—
even in the presence of fluid overload1†
reaching therapeutic plasma furosemide levels within 30 minutes‡
with urine output as early as 60 minutes1,2
self-administration at home through an on-body infusor designed for patient ease of use1,3
*
30 mg in the first hour, 12.5 mg per hour for the next 4 hours.
†
FUROSCIX is not for chronic use and should be replaced with oral diuretics as soon as practical.
‡
Based on mean ± SD 30-minute plasma concentration of 600 (± 209) ng/mL.1
SD=standard deviation.
Timely resolution of fluid overload episodes is of the utmost importance for your chronic kidney disease (ckd), heart failure, and cardiorenal patients
with furoscix, you can give your patients relief at the earliest signs and symptoms of fluid overload, such as1,4-6:
rapid weight gain
peripheral edema
dyspnea
